Flu Shots Industry Research Report 2025
Description
Summary
According to APO Research, the global Flu Shots market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Flu Shots include SANOFI, GSK, VAXTEC, TIANYUAN BIO-PHARMA, SIOBP, SINOVAC, LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT, HUALAN BIO and CHANGSHENG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Flu Shots, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Shots.
The report will help the Flu Shots manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Flu Shots market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flu Shots market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Flu Shots Segment by Company
SANOFI
GSK
VAXTEC
TIANYUAN BIO-PHARMA
SIOBP
SINOVAC
LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
HUALAN BIO
CHANGSHENG
CCBIO
ALEPH BIOMEDICAL
Flu Shots Segment by Type
Influenza Whole Virus Vaccines
Influenza Virus Subunit Vaccines
Influenza Virus Split Vaccines
Flu Shots Segment by Application
Avian Influenza Virus-A
Avian Influenza Virus-B
Flu Shots Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Shots market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Shots and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Shots.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Flu Shots manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Flu Shots by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Flu Shots in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Flu Shots market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Flu Shots include SANOFI, GSK, VAXTEC, TIANYUAN BIO-PHARMA, SIOBP, SINOVAC, LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT, HUALAN BIO and CHANGSHENG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Flu Shots, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Shots.
The report will help the Flu Shots manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Flu Shots market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flu Shots market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Flu Shots Segment by Company
SANOFI
GSK
VAXTEC
TIANYUAN BIO-PHARMA
SIOBP
SINOVAC
LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
HUALAN BIO
CHANGSHENG
CCBIO
ALEPH BIOMEDICAL
Flu Shots Segment by Type
Influenza Whole Virus Vaccines
Influenza Virus Subunit Vaccines
Influenza Virus Split Vaccines
Flu Shots Segment by Application
Avian Influenza Virus-A
Avian Influenza Virus-B
Flu Shots Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Shots market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Shots and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Shots.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Flu Shots manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Flu Shots by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Flu Shots in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Table of Contents
128 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Flu Shots Market Size (2020-2031)
- 2.2.2 Global Flu Shots Sales (2020-2031)
- 2.2.3 Global Flu Shots Market Average Price (2020-2031)
- 2.3 Flu Shots by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 Influenza Whole Virus Vaccines
- 2.3.3 Influenza Virus Subunit Vaccines
- 2.3.4 Influenza Virus Split Vaccines
- 2.4 Flu Shots by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Avian Influenza Virus-A
- 2.4.3 Avian Influenza Virus-B
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Flu Shots Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Flu Shots Sales (K Units) of Manufacturers (2020-2025)
- 3.3 Global Flu Shots Revenue of Manufacturers (2020-2025)
- 3.4 Global Flu Shots Average Price by Manufacturers (2020-2025)
- 3.5 Global Flu Shots Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Flu Shots, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Flu Shots, Product Type & Application
- 3.8 Global Manufacturers of Flu Shots, Established Date
- 3.9 Global Flu Shots Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 SANOFI
- 4.1.1 SANOFI Company Information
- 4.1.2 SANOFI Business Overview
- 4.1.3 SANOFI Flu Shots Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 SANOFI Flu Shots Product Portfolio
- 4.1.5 SANOFI Recent Developments
- 4.2 GSK
- 4.2.1 GSK Company Information
- 4.2.2 GSK Business Overview
- 4.2.3 GSK Flu Shots Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 GSK Flu Shots Product Portfolio
- 4.2.5 GSK Recent Developments
- 4.3 VAXTEC
- 4.3.1 VAXTEC Company Information
- 4.3.2 VAXTEC Business Overview
- 4.3.3 VAXTEC Flu Shots Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 VAXTEC Flu Shots Product Portfolio
- 4.3.5 VAXTEC Recent Developments
- 4.4 TIANYUAN BIO-PHARMA
- 4.4.1 TIANYUAN BIO-PHARMA Company Information
- 4.4.2 TIANYUAN BIO-PHARMA Business Overview
- 4.4.3 TIANYUAN BIO-PHARMA Flu Shots Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 TIANYUAN BIO-PHARMA Flu Shots Product Portfolio
- 4.4.5 TIANYUAN BIO-PHARMA Recent Developments
- 4.5 SIOBP
- 4.5.1 SIOBP Company Information
- 4.5.2 SIOBP Business Overview
- 4.5.3 SIOBP Flu Shots Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 SIOBP Flu Shots Product Portfolio
- 4.5.5 SIOBP Recent Developments
- 4.6 SINOVAC
- 4.6.1 SINOVAC Company Information
- 4.6.2 SINOVAC Business Overview
- 4.6.3 SINOVAC Flu Shots Sales, Revenue and Gross Margin (2020-2025)
- 4.6.4 SINOVAC Flu Shots Product Portfolio
- 4.6.5 SINOVAC Recent Developments
- 4.7 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
- 4.7.1 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Company Information
- 4.7.2 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Business Overview
- 4.7.3 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales, Revenue and Gross Margin (2020-2025)
- 4.7.4 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Product Portfolio
- 4.7.5 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Developments
- 4.8 HUALAN BIO
- 4.8.1 HUALAN BIO Company Information
- 4.8.2 HUALAN BIO Business Overview
- 4.8.3 HUALAN BIO Flu Shots Sales, Revenue and Gross Margin (2020-2025)
- 4.8.4 HUALAN BIO Flu Shots Product Portfolio
- 4.8.5 HUALAN BIO Recent Developments
- 4.9 CHANGSHENG
- 4.9.1 CHANGSHENG Company Information
- 4.9.2 CHANGSHENG Business Overview
- 4.9.3 CHANGSHENG Flu Shots Sales, Revenue and Gross Margin (2020-2025)
- 4.9.4 CHANGSHENG Flu Shots Product Portfolio
- 4.9.5 CHANGSHENG Recent Developments
- 4.10 CCBIO
- 4.10.1 CCBIO Company Information
- 4.10.2 CCBIO Business Overview
- 4.10.3 CCBIO Flu Shots Sales, Revenue and Gross Margin (2020-2025)
- 4.10.4 CCBIO Flu Shots Product Portfolio
- 4.10.5 CCBIO Recent Developments
- 4.11 ALEPH BIOMEDICAL
- 4.11.1 ALEPH BIOMEDICAL Company Information
- 4.11.2 ALEPH BIOMEDICAL Business Overview
- 4.11.3 ALEPH BIOMEDICAL Flu Shots Sales, Revenue and Gross Margin (2020-2025)
- 4.11.4 ALEPH BIOMEDICAL Flu Shots Product Portfolio
- 4.11.5 ALEPH BIOMEDICAL Recent Developments
- 5 Global Flu Shots Market Scenario by Region
- 5.1 Global Flu Shots Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Flu Shots Sales by Region: 2020-2031
- 5.2.1 Global Flu Shots Sales by Region: 2020-2025
- 5.2.2 Global Flu Shots Sales by Region: 2026-2031
- 5.3 Global Flu Shots Revenue by Region: 2020-2031
- 5.3.1 Global Flu Shots Revenue by Region: 2020-2025
- 5.3.2 Global Flu Shots Revenue by Region: 2026-2031
- 5.4 North America Flu Shots Market Facts & Figures by Country
- 5.4.1 North America Flu Shots Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Flu Shots Sales by Country (2020-2031)
- 5.4.3 North America Flu Shots Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Flu Shots Market Facts & Figures by Country
- 5.5.1 Europe Flu Shots Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Flu Shots Sales by Country (2020-2031)
- 5.5.3 Europe Flu Shots Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Flu Shots Market Facts & Figures by Country
- 5.6.1 Asia Pacific Flu Shots Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Flu Shots Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Flu Shots Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Flu Shots Market Facts & Figures by Country
- 5.7.1 South America Flu Shots Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Flu Shots Sales by Country (2020-2031)
- 5.7.3 South America Flu Shots Revenue by Country (2020-2031)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Flu Shots Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Flu Shots Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Flu Shots Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Flu Shots Revenue by Country (2020-2031)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
- 6 Segment by Type
- 6.1 Global Flu Shots Sales by Type (2020-2031)
- 6.1.1 Global Flu Shots Sales by Type (2020-2031) & (K Units)
- 6.1.2 Global Flu Shots Sales Market Share by Type (2020-2031)
- 6.2 Global Flu Shots Revenue by Type (2020-2031)
- 6.2.1 Global Flu Shots Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Flu Shots Revenue Market Share by Type (2020-2031)
- 6.3 Global Flu Shots Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Flu Shots Sales by Application (2020-2031)
- 7.1.1 Global Flu Shots Sales by Application (2020-2031) & (K Units)
- 7.1.2 Global Flu Shots Sales Market Share by Application (2020-2031)
- 7.2 Global Flu Shots Revenue by Application (2020-2031)
- 7.2.1 Global Flu Shots Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Flu Shots Revenue Market Share by Application (2020-2031)
- 7.3 Global Flu Shots Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Flu Shots Value Chain Analysis
- 8.1.1 Flu Shots Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Flu Shots Production Mode & Process
- 8.2 Flu Shots Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Flu Shots Distributors
- 8.2.3 Flu Shots Customers
- 9 Global Flu Shots Analyzing Market Dynamics
- 9.1 Flu Shots Industry Trends
- 9.2 Flu Shots Industry Drivers
- 9.3 Flu Shots Industry Opportunities and Challenges
- 9.4 Flu Shots Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Table 5. Global Flu Shots Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
- Table 6. Global Flu Shots Sales (K Units) of Manufacturers (2020-2025)
- Table 7. Global Flu Shots Sales Market Share by Manufacturers (2020-2025)
- Table 8. Global Flu Shots Revenue of Manufacturers (2020-2025)
- Table 9. Global Flu Shots Revenue Share by Manufacturers (2020-2025)
- Table 10. Global Market Flu Shots Average Price (US$/Unit) of Manufacturers (2020-2025)
- Table 11. Global Flu Shots Industry Ranking, 2023 VS 2024 VS 2025
- Table 12. Global Manufacturers of Flu Shots, Manufacturing Sites & Headquarters
- Table 13. Global Manufacturers of Flu Shots, Product Type & Application
- Table 14. Global Flu Shots Manufacturers Established Date
- Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 16. Global Flu Shots by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
- Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
- Table 18. SANOFI Company Information
- Table 19. SANOFI Business Overview
- Table 20. SANOFI Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 21. SANOFI Flu Shots Product Portfolio
- Table 22. SANOFI Recent Developments
- Table 23. GSK Company Information
- Table 24. GSK Business Overview
- Table 25. GSK Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 26. GSK Flu Shots Product Portfolio
- Table 27. GSK Recent Developments
- Table 28. VAXTEC Company Information
- Table 29. VAXTEC Business Overview
- Table 30. VAXTEC Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 31. VAXTEC Flu Shots Product Portfolio
- Table 32. VAXTEC Recent Developments
- Table 33. TIANYUAN BIO-PHARMA Company Information
- Table 34. TIANYUAN BIO-PHARMA Business Overview
- Table 35. TIANYUAN BIO-PHARMA Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 36. TIANYUAN BIO-PHARMA Flu Shots Product Portfolio
- Table 37. TIANYUAN BIO-PHARMA Recent Developments
- Table 38. SIOBP Company Information
- Table 39. SIOBP Business Overview
- Table 40. SIOBP Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 41. SIOBP Flu Shots Product Portfolio
- Table 42. SIOBP Recent Developments
- Table 43. SINOVAC Company Information
- Table 44. SINOVAC Business Overview
- Table 45. SINOVAC Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 46. SINOVAC Flu Shots Product Portfolio
- Table 47. SINOVAC Recent Developments
- Table 48. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Company Information
- Table 49. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Business Overview
- Table 50. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 51. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Product Portfolio
- Table 52. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Developments
- Table 53. HUALAN BIO Company Information
- Table 54. HUALAN BIO Business Overview
- Table 55. HUALAN BIO Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 56. HUALAN BIO Flu Shots Product Portfolio
- Table 57. HUALAN BIO Recent Developments
- Table 58. CHANGSHENG Company Information
- Table 59. CHANGSHENG Business Overview
- Table 60. CHANGSHENG Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 61. CHANGSHENG Flu Shots Product Portfolio
- Table 62. CHANGSHENG Recent Developments
- Table 63. CCBIO Company Information
- Table 64. CCBIO Business Overview
- Table 65. CCBIO Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 66. CCBIO Flu Shots Product Portfolio
- Table 67. CCBIO Recent Developments
- Table 68. ALEPH BIOMEDICAL Company Information
- Table 69. ALEPH BIOMEDICAL Business Overview
- Table 70. ALEPH BIOMEDICAL Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 71. ALEPH BIOMEDICAL Flu Shots Product Portfolio
- Table 72. ALEPH BIOMEDICAL Recent Developments
- Table 73. Global Flu Shots Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Table 74. Global Flu Shots Sales by Region (2020-2025) & (K Units)
- Table 75. Global Flu Shots Sales Market Share by Region (2020-2025)
- Table 76. Global Flu Shots Sales by Region (2026-2031) & (K Units)
- Table 77. Global Flu Shots Sales Market Share by Region (2026-2031)
- Table 78. Global Flu Shots Revenue by Region (2020-2025) & (US$ Million)
- Table 79. Global Flu Shots Revenue Market Share by Region (2020-2025)
- Table 80. Global Flu Shots Revenue by Region (2026-2031) & (US$ Million)
- Table 81. Global Flu Shots Revenue Market Share by Region (2026-2031)
- Table 82. North America Flu Shots Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 83. North America Flu Shots Sales by Country (2020-2025) & (K Units)
- Table 84. North America Flu Shots Sales by Country (2026-2031) & (K Units)
- Table 85. North America Flu Shots Revenue by Country (2020-2025) & (US$ Million)
- Table 86. North America Flu Shots Revenue by Country (2026-2031) & (US$ Million)
- Table 87. Europe Flu Shots Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 88. Europe Flu Shots Sales by Country (2020-2025) & (K Units)
- Table 89. Europe Flu Shots Sales by Country (2026-2031) & (K Units)
- Table 90. Europe Flu Shots Revenue by Country (2020-2025) & (US$ Million)
- Table 91. Europe Flu Shots Revenue by Country (2026-2031) & (US$ Million)
- Table 92. Asia Pacific Flu Shots Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 93. Asia Pacific Flu Shots Sales by Country (2020-2025) & (K Units)
- Table 94. Asia Pacific Flu Shots Sales by Country (2026-2031) & (K Units)
- Table 95. Asia Pacific Flu Shots Revenue by Country (2020-2025) & (US$ Million)
- Table 96. Asia Pacific Flu Shots Revenue by Country (2026-2031) & (US$ Million)
- Table 97. South America Flu Shots Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 98. South America Flu Shots Sales by Country (2020-2025) & (K Units)
- Table 99. South America Flu Shots Sales by Country (2026-2031) & (K Units)
- Table 100. South America Flu Shots Revenue by Country (2020-2025) & (US$ Million)
- Table 101. South America Flu Shots Revenue by Country (2026-2031) & (US$ Million)
- Table 102. Middle East and Africa Flu Shots Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 103. Middle East and Africa Flu Shots Sales by Country (2020-2025) & (K Units)
- Table 104. Middle East and Africa Flu Shots Sales by Country (2026-2031) & (K Units)
- Table 105. Middle East and Africa Flu Shots Revenue by Country (2020-2025) & (US$ Million)
- Table 106. Middle East and Africa Flu Shots Revenue by Country (2026-2031) & (US$ Million)
- Table 107. Global Flu Shots Sales by Type (2020-2025) & (K Units)
- Table 108. Global Flu Shots Sales by Type (2026-2031) & (K Units)
- Table 109. Global Flu Shots Sales Market Share by Type (2020-2025)
- Table 110. Global Flu Shots Sales Market Share by Type (2026-2031)
- Table 111. Global Flu Shots Revenue by Type (2020-2025) & (US$ Million)
- Table 112. Global Flu Shots Revenue by Type (2026-2031) & (US$ Million)
- Table 113. Global Flu Shots Revenue Market Share by Type (2020-2025)
- Table 114. Global Flu Shots Revenue Market Share by Type (2026-2031)
- Table 115. Global Flu Shots Price by Type (2020-2025) & (US$/Unit)
- Table 116. Global Flu Shots Price by Type (2026-2031) & (US$/Unit)
- Table 117. Global Flu Shots Sales by Application (2020-2025) & (K Units)
- Table 118. Global Flu Shots Sales by Application (2026-2031) & (K Units)
- Table 119. Global Flu Shots Sales Market Share by Application (2020-2025)
- Table 120. Global Flu Shots Sales Market Share by Application (2026-2031)
- Table 121. Global Flu Shots Revenue by Application (2020-2025) & (US$ Million)
- Table 122. Global Flu Shots Revenue by Application (2026-2031) & (US$ Million)
- Table 123. Global Flu Shots Revenue Market Share by Application (2020-2025)
- Table 124. Global Flu Shots Revenue Market Share by Application (2026-2031)
- Table 125. Global Flu Shots Price by Application (2020-2025) & (US$/Unit)
- Table 126. Global Flu Shots Price by Application (2026-2031) & (US$/Unit)
- Table 127. Key Raw Materials
- Table 128. Raw Materials Key Suppliers
- Table 129. Flu Shots Distributors List
- Table 130. Flu Shots Customers List
- Table 131. Flu Shots Industry Trends
- Table 132. Flu Shots Industry Drivers
- Table 133. Flu Shots Industry Restraints
- Table 134. Authors List of This Report
- List of Figures
- Figure 1. Research Methodology
- Figure 2. Research Process
- Figure 3. Key Executives Interviewed
- Figure 4. Flu Shots Product Image
- Figure 5. Global Flu Shots Revenue (US$ Million), 2020 VS 2024 VS 2031
- Figure 6. Global Flu Shots Market Size (2020-2031) & (US$ Million)
- Figure 7. Global Flu Shots Sales (2020-2031) & (K Units)
- Figure 8. Global Flu Shots Average Price (US$/Unit) & (2020-2031)
- Figure 9. Influenza Whole Virus Vaccines Product Image
- Figure 10. Influenza Virus Subunit Vaccines Product Image
- Figure 11. Influenza Virus Split Vaccines Product Image
- Figure 12. Avian Influenza Virus-A Product Image
- Figure 13. Avian Influenza Virus-B Product Image
- Figure 14. Global Flu Shots Revenue Share by Manufacturers in 2024
- Figure 15. Global Manufacturers of Flu Shots, Manufacturing Sites & Headquarters
- Figure 16. Global Top 5 and 10 Flu Shots Players Market Share by Revenue in 2024
- Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 18. Global Flu Shots Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Figure 19. Global Flu Shots Sales by Region in 2024
- Figure 20. Global Flu Shots Revenue by Region in 2024
- Figure 21. North America Flu Shots Market Size by Country in 2024
- Figure 22. North America Flu Shots Sales Market Share by Country (2020-2031)
- Figure 23. North America Flu Shots Revenue Market Share by Country (2020-2031)
- Figure 24. United States Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 25. Canada Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 26. Europe Flu Shots Market Size by Country in 2024
- Figure 27. Europe Flu Shots Sales Market Share by Country (2020-2031)
- Figure 28. Europe Flu Shots Revenue Market Share by Country (2020-2031)
- Figure 29. Germany Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 30. France Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 31. U.K. Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 32. Italy Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 33. Netherlands Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 34. Asia Pacific Flu Shots Market Size by Country in 2024
- Figure 35. Asia Pacific Flu Shots Sales Market Share by Country (2020-2031)
- Figure 36. Asia Pacific Flu Shots Revenue Market Share by Country (2020-2031)
- Figure 37. China Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 38. Japan Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 39. South Korea Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 40. India Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 41. Australia Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 42. China Taiwan Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 43. Southeast Asia Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 44. Southeast Asia Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 45. South America Flu Shots Market Size by Country in 2024
- Figure 46. South America Flu Shots Sales Market Share by Country (2020-2031)
- Figure 47. South America Flu Shots Revenue Market Share by Country (2020-2031)
- Figure 48. Mexico Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 49. Brazil Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 50. Argentina Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 51. Middle East and Africa Flu Shots Market Size by Country in 2024
- Figure 52. Middle East and Africa Flu Shots Sales Market Share by Country (2020-2031)
- Figure 53. Middle East and Africa Flu Shots Revenue Market Share by Country (2020-2031)
- Figure 54. Turkey Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 55. Saudi Arabia Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 56. UAE Flu Shots Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 57. Global Flu Shots Sales Market Share by Type (2020-2031)
- Figure 58. Global Flu Shots Revenue Market Share by Type (2020-2031)
- Figure 59. Global Flu Shots Price (US$/Unit) by Type (2020-2031)
- Figure 60. Global Flu Shots Sales Market Share by Application (2020-2031)
- Figure 61. Global Flu Shots Revenue Market Share by Application (2020-2031)
- Figure 62. Global Flu Shots Price (US$/Unit) by Application (2020-2031)
- Figure 63. Flu Shots Value Chain
- Figure 64. Flu Shots Production Mode & Process
- Figure 65. Direct Comparison with Distribution Share
- Figure 66. Distributors Profiles
- Figure 67. Flu Shots Industry Opportunities and Challenges
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


